Day three: Commercialization - ET (Eastern Time, GMT-05:00)
Beyond the Bench and Building Biotech Powerhouses Join industry pioneers as they decode the critical success factors transforming biotech startups into market leaders. This dynamic panel explores the intersection of scientific innovation, strategic capital deployment, and governance frameworks that drive sustainable growth in today's rapidly evolving life sciences landscape.
• Capital & Scale: How do biotech leaders balance aggressive growth ambitions with capital efficiency while navigating the challenging path from Series A to IPO and beyond?
• Governance as Competitive Advantage: What governance structures and board compositions enable biotech companies to make faster, smarter decisions while maintaining regulatory compliance and stakeholder confidence?
• Value Creation Beyond Valuation: How are leading biotech executives redefining success metrics to encompass patient outcomes, partnership ecosystems, and long-term strategic positioning rather than focusing solely on exit multiples?
- Björn Cochlovius - CEO, eleva
- David Solomon - CEO, Thalia Therapeutics
